赛孚士搭建了国内领先的细胞系开发、细胞培养工艺开发、纯化工艺开发、制剂工艺开发及商业化生产等技术平台，拥有丰富的抗体药物CMC管理及注册申报经验，可为客户提供符合NMPA、FDA及EMA等标准的高质量、一站式、定制化CDMO服务，服务内容涵盖从分子设计与评价、工艺开发、临床样品生产、分析与质量管理、注册申报到商业化生产的全链条环节。赛孚士现已与多家抗体药领域高新技术企业达成联盟合作关系，同时积极拓展海外委托生产业务。赛孚士致力构筑生物医药产业生态圈，与生态伙伴共生共赢，愿成为每一位客户值得信赖的伙伴。

Cellularforce Biopharma has built a domestic leading technology platform for cell line development, cell culture process development, purification process development, preparation process development and commercial production. It has rich experience in antibody drug CMC management and registration application, and can provide customers with high-quality, one-stop, customized CDMO services that meet standards such as NMPA, FDA and EMA. The services cover molecular design and evaluation, process development, manufacturing, clinical sample analysis and quality management, and registration. Cellularforce Biopharma has reached alliance and cooperation with many high-tech enterprises in the field of antibody drugs, and actively expanded overseas entrusted production business. Cellularforce Biopharma is committed to building an ecosystem of bio pharmaceutical industry, symbiosis and win-win with ecological partners, and is willing to become a trusted partner for every customer.